Growing community of inventors

Tainan, Taiwan

K C Sung

Average Co-Inventor Count = 5.60

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 16

K C SungFang-Yu Liu (7 patents)K C SungChi-Cheng Lin (6 patents)K C SungChin-Yao Yang (6 patents)K C SungYi-Hsin Lin (5 patents)K C SungLi Qiao (5 patents)K C SungYu Zhang (1 patent)K C SungGeorge Kraft (1 patent)K C SungJohn Duan (1 patent)K C SungShang Wei Qin (1 patent)K C SungK C Sung (7 patents)Fang-Yu LiuFang-Yu Liu (11 patents)Chi-Cheng LinChi-Cheng Lin (10 patents)Chin-Yao YangChin-Yao Yang (7 patents)Yi-Hsin LinYi-Hsin Lin (6 patents)Li QiaoLi Qiao (6 patents)Yu ZhangYu Zhang (37 patents)George KraftGeorge Kraft (4 patents)John DuanJohn Duan (4 patents)Shang Wei QinShang Wei Qin (4 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Handa Oncology, LLC (5 from 9 patents)

2. Handa Pharmaceuticals LLC (1 from 5 patents)

3. Handa Onocology, LLC (1 from 1 patent)


7 patents:

1. 12516025 - Cabozantinib compositions and methods of use

2. 12064428 - Kinase inhibitor salts and compositions thereof

3. 12064430 - Kinase inhibitor salts and compositions thereof

4. 11160805 - Kinase inhibitor salts and compositions thereof

5. 11052088 - Kinase inhibitor salts, and compositions thereof

6. 10940149 - Kinase inhibitor salts and compositions thereof

7. 10098898 - Release stable mesalamine dosage forms

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/15/2026
Loading…